Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Discussion on Current and Future Management Strategies
2:02:17
2:02:17
Spela senare
Spela senare
Listor
Gilla
Gillad
2:02:17Dr Joyce O’Shaughnessy from Sarah Cannon Research Institute in Dallas, Texas, Dr Mark D Pegram from Stanford Cancer Institute in California, and Prof Peter Schmid from Barts Cancer Institute in London, United Kingdom, summarize currently available data guiding treatment decision-making for patients with low and ultralow HER2 expression and present …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Hepatocellular Carcinoma — Proceedings From a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)
1:58:47
1:58:47
Spela senare
Spela senare
Listor
Gilla
Gillad
1:58:47Dr Anthony El-Khoueiry, Dr Richard Finn, Dr Aiwu Ruth He, Dr Stacey Stein and moderator Dr Stephen “Fred” Divers discuss data from the 2025 ASCO GI meeting and other published studies guiding the care of patients with hepatocellular carcinoma. CME information and select publications here.Av Research To Practice
…
continue reading
![Artwork](/static/images/128pixel.png)
1
5-Minute Journal Club Issue 4 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
10:06
10:06
Spela senare
Spela senare
Listor
Gilla
Gillad
10:06Dr Seth Wander from Massachusetts General Hospital in Boston discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer. CME information and select publications hereAv Research To Practice
…
continue reading
![Artwork](/static/images/128pixel.png)
1
EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
1:00:02
1:00:02
Spela senare
Spela senare
Listor
Gilla
Gillad
1:00:02Dr Enriqueta Felip from the Vall d’Hebron Institute of Oncology in Barcelona, Spain, and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New York, New York, discuss current and emerging treatment approaches for patients with EGFR-mutant non-small cell lung cancer. CME information and select publications here…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani
46:45
46:45
Spela senare
Spela senare
Listor
Gilla
Gillad
46:45Dr Saad Zafar Usmani from Memorial Sloan Kettering Cancer Center in New York discusses available data guiding treatment decision-making for patients with newly diagnosed multiple myeloma. CME information and select publications here.Av Research To Practice
…
continue reading